Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F4IM
|
|||
Drug Name |
Adcetris
|
|||
Indication | Cutaneous T-cell lymphoma [ICD-11: 2B01; ICD-10: C84.8; ICD-9: 202.1, 202.2] | Phase 3 | [1], [2] | |
Hodgkin lymphoma [ICD-11: 2B30; ICD-10: C81, C81.9] | Phase 3 | [1], [3] | ||
T-cell leukaemia [ICD-11: 2A90; ICD-10: C86] | Phase 3 | [1], [3] | ||
Diffuse large B-cell lymphoma [ICD-11: 2A81; ICD-10: C83.3; ICD-9: 200] | Phase 2 | [1] | ||
Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 2 | [1], [3] | ||
Company |
Seattle Genetics Bothell, WA
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.